An abundant merozoite surface protein of Plasmodium falciparum modulates susceptibility to inhibitory antibodies
eLife · 27.07.2026 · 14
DOI: 10.7554/elife.107603.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 27.07.2026. Verfasst von Isabelle G Henshall und 10 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council, Hospital Research Foundation, National Health and Medical Research Council.
Abstract (Originalsprache)
Malaria merozoite surface proteins (MSPs) are thought to have important roles in red blood cell (RBC) invasion and their exposure on the parasite surface makes them attractive vaccine candidates. However, their role in invasion has not been directly demonstrated and their biological functions remain unknown. One of the most abundant merozoite surface proteins is Pf MSP2, a likely ancestral protein that has been maintained in the Plasmodium falciparum lineage and is a focus of vaccine development. Using CRISPR-Cas9 gene editing, we removed Pf MSP2 from two different P. falciparum lines with no impact on parasite replication or phenotype in vitro, demonstrating that it is not essential for RBC invasion. Interestingly, loss of Pf MSP2 led to increased inhibitory potency of antibodies targeting other merozoite proteins involved in invasion, particularly Pf AMA1. In a solid-phase model, increasing concentrations of Pf MSP2 protein reduced binding of different antibodies against Pf AMA1 in a dose-dependent manner. These data suggest that Pf MSP2 can modulate the susceptibility of merozoites to protective inhibitory antibodies. The results of this study change our understanding of the potential functions of Pf MSP2 and establish a new concept in malaria where a surface protein can reduce the protective efficacy of antibodies targeting a different antigen. These findings have important implications for understanding malaria immunity and informing vaccine development.
Förderung
- Australian Research Council
- Hospital Research Foundation
- National Health and Medical Research Council
Zitieren
APA
Henshall, I. G., Chmielewski, J., Angage, D., Romeo, O., Lai, K. H., Turland, K. R., Badii, N., Foley, M., Anders, R. F., Beeson, J. G., & Wilson, D. W. (2026). An abundant merozoite surface protein of Plasmodium falciparum modulates susceptibility to inhibitory antibodies. eLife, 14. https://doi.org/10.7554/elife.107603.4
Vancouver
Henshall IG, Chmielewski J, Angage D, Romeo O, Lai KH, Turland KR, et al. An abundant merozoite surface protein of Plasmodium falciparum modulates susceptibility to inhibitory antibodies. eLife. 2026;14. doi:10.7554/elife.107603.4
BibTeX
@article{Henshall2026,
author = {Henshall, Isabelle G and Chmielewski, Jill and Angage, Dimuthu and Romeo, Ornella and Lai, Keng Heng and Turland, Kaitlin R and Badii, Nicki and Foley, Michael and Anders, Robin F and Beeson, James G and Wilson, Danny W},
title = {An abundant merozoite surface protein of Plasmodium falciparum modulates susceptibility to inhibitory antibodies},
journal = {eLife},
year = {2026},
volume = {14},
doi = {10.7554/elife.107603.4}
}
EUVIMED